<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-10">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Ebola Virus</title>
    <style>
        body {
             background-color: #F4F4F4; 
            color: 333333; 
             font-family: Arial, sans-serif;
        }
        table, th, td {
            border: 1px solid white;
            border-collapse: collapse;
        }
 h1 {
            color: #0056b3; /* Темно-синий заголовок */
        }

    </style>
</head>
<body>
    <h1>Ebola Virus</h1>

    <img src="https://imageio.forbes.com/specials-images/imageserve/6036bc5aebb0961679950dfb/0x0.jpg?format=jpg&amp;width=300" alt="Ebola virus image">

    <h2>What is Ebola?</h2>
    <p>Ebola is a severe, often fatal disease caused by a virus. It is in the family of filoviruses, which are a group of viruses that cause hemorrhagic fever. The virus is named
 after the Ebola River in the Democratic Republic of the Congo, where the virus was first discovered in 1976.
Species: Zaire ebolavirus, Sudan ebolavirus, Bundibugyo ebolavirus, Tai Forest ebolavirus, and Reston ebolavirus
Medical Explanation:
Ebola virus disease (EVD) is characterized by a sudden onset of fever, intense weakness, muscle pain, headache, and sore throat. This is followed by vomiting, diarrhea, rash, impaired 
kidney and liver function, and, in some cases, both internal and external bleeding. The average Ebola virus incubation period is 8 days (range 2 to 21 days).
Impact on Humans:
Ebola outbreaks have a devastating impact on individuals, communities, and healthcare systems. The disease has a high mortality rate, and survivors may experience long-term health effects.
Ebola outbreaks can also disrupt economies, undermine social cohesion, and exacerbate existing health problems.
</p>

    <h2>How is Ebola spread?</h2>
    <p>Ebola is primarily transmitted through direct contact with the bodily fluids of a person or animal infected with the virus. This means that people can become infected if they come into contact with blood, saliva, sweat, urine, feces, vomit, breast milk, or semen from someone who is sick with or has died from Ebola. These fluids must enter the body through broken skin or mucous membranes, such as those found in the eyes, nose, or mouth. For example, a person can contract Ebola if they touch contaminated fluids and then touch their face.

Transmission can also occur indirectly through contact with objects or surfaces that have been contaminated by these fluids. Items such as bedding, clothing, medical equipment, or needles that have been exposed to the virus can serve as sources of infection. Caregivers, including family members and healthcare workers, are at high risk of contracting the virus when treating Ebola patients if they do not use appropriate protective gear, such as gloves, gowns, and face masks.

Ebola can also be spread through contact with infected animals. In Africa, fruit bats are believed to be the natural hosts of the Ebola virus, and the disease can spread to humans through handling or consuming infected animals, including bats, primates (such as chimpanzees and gorillas), and other wildlife. This often occurs when people hunt, butcher, or consume these animals. 

It is important to note that Ebola is not spread through the air, water, or food, except in the case of infected animals. The virus is also not known to be transmitted by mosquitoes or other insects. However, the virus can remain present in certain bodily fluids, such as semen, even after a person has recovered from the illness, which means survivors may still be capable of transmitting the virus for a period of time after recovery.

Preventing the spread of Ebola involves early detection, isolation of infected individuals, and strict adherence to infection control measures. Proper use of personal protective equipment (PPE), safe burial practices, and public health education are critical in controlling outbreaks. </p>

    <h2>Symptoms</h2>
    <p>Ebola symptoms typically appear 2 to 21 days after exposure to the virus, with an average onset time of 8 to 10 days. The symptoms can be severe and progress rapidly. Initial symptoms are often mistaken for other common illnesses, but as the disease progresses, more serious symptoms develop. Common symptoms include:</p>
    
    <ul>
        <li>Fever</li>
        <li>Severe headache</li>
        <li>Muscle pain</li>
        <li>Fatigue and weakness</li>
        <li>Sore throat</li>
        <li>Diarrhea</li>
        <li>Vomiting</li>
        <li>Stomach pain</li>
        <li>Unexplained bleeding or bruising</li>
    </ul>

    <p>As the disease progresses, more severe symptoms such as internal and external bleeding, organ failure, and shock may occur. Immediate medical attention is crucial for anyone displaying these symptoms, especially if they have been exposed to Ebola or have traveled to an area with an ongoing outbreak.</p>


    <h2>Treatment and Prevention</h2>
    <h2>Treatment</h2>
    <p>There is no specific, approved antiviral treatment for Ebola virus disease, but supportive care and treatment of symptoms can significantly improve chances of survival. Current treatment methods focus on the following:</p>
    
    <ul>
        <li>Providing intravenous fluids (IV) and maintaining electrolytes</li>
        <li>Maintaining oxygen levels and blood pressure</li>
        <li>Treating any complicating infections</li>
        <li>Managing symptoms such as fever, pain, and diarrhea</li>
    </ul>
    
    <p>Several experimental treatments and vaccines have been developed and used during outbreaks, some of which have shown promise in reducing the severity of the disease. The development of the rVSV-ZEBOV vaccine has been a breakthrough in preventing Ebola outbreaks in areas with high transmission risk.</p>

    <h2>Prevention</h2>
    <p>Prevention of Ebola is crucial, especially in regions where the virus is endemic. Key prevention measures include:</p>

    <ul>
        <li>Avoiding direct contact with the blood or bodily fluids of infected individuals</li>
        <li>Using proper personal protective equipment (PPE), such as gloves and masks, when caring for Ebola patients</li>
        <li>Practicing good hand hygiene, washing hands with soap and water or using an alcohol-based hand sanitizer</li>
        <li>Avoiding contact with animals that may carry the virus, particularly fruit bats, monkeys, and apes</li>
        <li>Ensuring safe burial practices to minimize exposure to the virus from deceased individuals</li>
        <li>Receiving vaccinations if available, especially for healthcare workers and individuals in high-risk areas</li>
    </ul>

    <p>Public health education, prompt identification of cases, and quarantine measures are also critical in controlling the spread of the virus during outbreaks. Healthcare workers and first responders play a crucial role in preventing transmission by adhering to strict infection control protocols.</p>


     <title>Ebola Virus Classification</title>
    <style>
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
        }

        th, td {
            border: 1px solid #dddddd;
            text-align: left;
            padding: 8px;
        }

        th {
            background-color: #f2f2f2;
        }
    </style>
</head>
<body>
    <h1>Ebola Virus Classification</h1>

    <table>
        <thead>
            <tr>
                <th>Type of Ebola Virus</th>
                <th>Geographic Location</th>
                <th>Mortality Rate</th>
                <th>Year Discovered</th>
            </tr>
        </thead>
        <tbody>
            <tr>
                <td>Zaire ebolavirus (EBOV)</td>
                <td>Central Africa</td>
                <td>Up to 90%</td>
                <td>1976</td>
            </tr>
            <tr>
                <td>Sudan ebolavirus (SUDV)</td>
                <td>East Africa</td>
                <td>50% to 60%</td>
                <td>1976</td>
            </tr>
            <tr>
                <td>Bundibugyo ebolavirus (BDBV)</td>
                <td>Central Africa</td>
                <td>25% to 50%</td>
                <td>2007</td>
            </tr>
            <tr>
                <td>Reston ebolavirus (RESTV)</td>
                <td>Philippines, China</td>
                <td>Non-fatal in humans</td>
                <td>1989</td>
            </tr>
            <tr>
                <td>Taï Forest ebolavirus (TAFV)</td>
                <td>West Africa (Côte d'Ivoire)</td>
                <td>Unknown</td>
                <td>1994</td>
            </tr>
            <tr>
                <td>Bombali ebolavirus (BOMV)</td>
                <td>West Africa</td>
                <td>Unknown</td>
                <td>2018</td>
            </tr>
        </tbody>
    </table>

</body>
</html>
